Table 3.
Characteristics of the Original Aurora AF Warfarin and Aurora Clinical Avatar Populations
Characteristic | Aurora AF Warfarin Population (mean±SD) | Aurora Clinical Avatar Population (mean±SD) |
---|---|---|
| ||
Age, year, | 67.3±14.43 | 67.2±14.47 |
| ||
Weight, lb, | 199.24±54.71 | 199.24±54.6 |
| ||
Height, in, | 66.78±4.31 | 66.53±4.32 |
| ||
Gender, % | ||
Female | 53.14 | 53.10 |
Male | 46.86 | 46.90 |
| ||
Race, % | ||
White | 95.18 | 95.22 |
African-American | 4.25 | 4.19 |
Asian | 0.39 | 0.40 |
Am. Indian/Alaskan | 0.18 | 0.18 |
Pacific Islander | 0.0001 | 0.0001 |
| ||
Tobacco, % | ||
No | 90.33 | 90.67 |
Yes | 9.66 | 9.33 |
| ||
Amiodarone, % | ||
No | 88.45 | 88.49 |
Yes | 11.54 | 11.51 |
| ||
Fluvastatin, % | ||
No | 99.97 | 99.98 |
Yes | 0.03 | 0.02 |
| ||
CYP2C9, % | ||
*1/*1 | 65.77* | 67.39 |
*1/*2 | 14.6* | 14.86 |
*1/*3 | 9.11* | 9.25 |
*2/*2 | 6.41* | 6.51 |
*2/*3 | 1.93* | 1.97 |
*3/*3 | 0* | 0 |
| ||
VKORC1, % | ||
G/G | 38.54* | 38.37 |
G/A | 44.02* | 44.18 |
A/A | 17.33* | 17.45 |
Aurora patient population’s genotypic characteristics were derived from published genotype distributions.35